Monday , December 18 2017
Home / Resources / Polls (page 3)

Polls

Patient Motivation

Do you agree with the statement: Doing a monthly A1c test could act as a way to motivate patients to better care? Follow the link to share your response and see what your colleagues think!

Read More »

A1c for Metformin

At what A1c level would you recommend the use of metformin? 1. 5.6% 2. 5.7 – 5.9% 3. 6.0% 4. 6.1 – 6.2% 5. 6.3 – 6.4% 6. 6.5 – 7% Follow the link to share your response.

Read More »

Additional Testing

Which additional test do you prefer to use when doing a physical exam? 1. A fasting blood glucose 2. An A1c 3. Neither Follow the link to share your opinion!

Read More »

Type 2 Blood Sugar Monitoring

How often do you recommend to your patients with type 2 who do not take insulin that they monitor their blood glucose? 1) Once daily in the AM 2) Twice daily in the AM and after 1 meal 3) 3 or 4 times daily 2 to 3 times a week 4) Other Follow the link to see how you compare to your colleagues.

Read More »

SGLT-2 / GLP-1 Combo

Would you consider using a combination of SGLT-2 Inhibitor along with an GLP-1 Agonist, now or in the future? Follow the link to see how you and your colleagues compare!

Read More »

Patients on SGLT-2

Approximately what percentage of type 2 patients do you have on SGLT-2 Inhibitors? 1. None 2. 5% 3. 10% 4. 15% 5. 20% or greater Follow the link to see how you and your colleagues compare!

Read More »

Drug Class Preferences

Which class of drugs would you prefer for a person with an A1c of 5.6%? 1) Only diet and exercise information 2) A GLP-1 receptor agonist 3) SGLT-2 Inhibitor 4) Metformin 5) Sulfonylurea Follow the link to share your opinion and see what your colleagues think!

Read More »

Prediabetes Diagnosis Test

Which test do you use to determine if a patient has prediabetes? 1) fasting blood sugar 2) A1c 3) OGTT 4) Random blood sugar Follow the link to see how you and your colleagues compare!

Read More »

Recommending GLP-1

To your type 1 patients who use large amounts of insulin or are overweight, have you recommended the use of a GLP-1 receptor agonist in their treatment? (See Article #3) 1) Yes 2) No 3) No, but will now consider What do your colleagues think? Follow the link to find out!

Read More »